Oxcia AB is developing a first-in-class oncology lead candidate in two ongoing phase I trials and a novel therapy to inhibit inflammation and fibrosis
,
Founded in 2014
11-50 employees
Oxcia AB is developing a first-in-class oncology lead candidate in two ongoing phase I trials and a novel therapy to inhibit inflammation and fibrosis
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2014
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Norrbackagatan 70C Stockholm
- City
- Region
- Postal Code
- Country
- Sweden
Web Presence
Websiteoxcia.com
LinkedIn0 followers